Latest Breaking News On - Anant narayan bhatt - Page 1 : comparemela.com
DRDO s anti-Covid drug 2-DG found effective against all variants: Study
indiatoday.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatoday.in Daily Mail and Mail on Sunday newspapers.
2-DG effective against all Covid variants, says study
prokerala.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prokerala.com Daily Mail and Mail on Sunday newspapers.
Union Defence Minister, Rajnath Singh (Photo/ANI)
Rajnath Singh to release first batch of DRDO s 2DG medicine for treating COVID-19 patients today ANI | Updated: May 17, 2021 04:49 IST
New Delhi [India], May 17 (ANI): The first batch of the 2-deoxy-D-glucose (2-DG) drug developed by the Defence Research and Development Organisation (DRDO) for treatment of Covid-19 will be released by Defence Minister Rajnath Singh on Monday.
Rajnath Singh s office tweeted, Raksha Mantri Rajnath Singh will release the first batch of anti-Covid drug 2DG via video conferencing facility tomorrow at 10.30 AM. The drug has been developed by DRDO s Institute of Nuclear Medicine and Allied Sciences (INMAS) in collaboration with Dr Reddy s Laboratories.
The first batch of the 2-deoxy-D-glucose (2-DG) drug developed by the Defence Research and Development Organisation (DRDO) for treatment of Covid-19 will be released by Defence Minister Rajnath Singh on Monday. Rajnath Singh s office tweeted, Raksha Mantri Rajnath Singh will release the first batch of anti-Covid drug 2DG via video conferencing facility tomorrow at 10.30 AM. The drug has been developed by DRDO s Institute of Nuclear Medicine and Allied Sciences (INMAS) in collaboration with Dr Reddy s Laboratories. The first batch of 10,000 doses of 2DG medicine would be launched early next week, informed Defence Research and Development Organisation officials to ANI on Friday.
DRDO to launch 2-DG drug for COVID-19 treatment next week
The first batch of 10,000 doses of 2DG medicine for treating coronavirus patients will be launched early next week, informed Defence Research and Development Organisation (DRDO) officials
BusinessToday.In | May 15, 2021 | Updated 11:53 IST
The 2-DG drug helps in faster recovery of the hospitalised COVID-19 patients and also lessens oxygen dependence
The first tranche of 10,000 doses of 2-DG medicine for treating coronavirus patients will be launched early next week, informed Defence Research and Development Organisation (DRDO) officials on Friday, May 14.
The 2-DG (2-deoxy-D-glucose), an anti-COVID-19 therapeutic application of the drug, has been developed by the Institute of Nuclear Medicine and Allied Sciences (INMAS), a lab of Defence Research and Development Organisation (DRDO), in collaboration with Dr Reddys Laboratories (DRL), Hyderabad.
vimarsana © 2020. All Rights Reserved.